Literature DB >> 25879329

Raman spectroscopy in cervical cancers: an update.

S Rubina, C Murali Krishna1.   

Abstract

Cervical cancer is the third most common cancer among women worldwide. Developing countries contribute more than 80% towards global burden. Over the last 2 decades, Raman spectroscopy (RS) has been actively pursued for cervical cancer detection. In view of latest development in Raman spectroscopic applications in cervical cancers, especially in vivo studies, an update of the same is presented in this article. This articles opens with a brief note on Anatomy of cervix followed by Etiology, and conventional Screening and Diagnosis of Cervical cancers. In subsequent sections, brief description of Theory and Instrumentation of RS is followed by a review of recent developments in cervical cancer detection; with emphasis on cell lines, exfoliated cells, ex vivo and in vivo, and therapeutic response monitoring applications in cervical cancer.

Entities:  

Mesh:

Year:  2015        PMID: 25879329     DOI: 10.4103/0973-1482.154065

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  3 in total

Review 1.  Challenges and opportunities in clinical translation of biomedical optical spectroscopy and imaging.

Authors:  Brian C Wilson; Michael Jermyn; Frederic Leblond
Journal:  J Biomed Opt       Date:  2018-03       Impact factor: 3.170

2.  Retracted Article: RNA-sequencing identified miR-3681 as a negative regulator in the proliferation and migration of cervical cancer cells via the posttranscriptional suppression of HGFR.

Authors:  Fan Shi; Yingbing Zhang; Juan Wang; Jin Su; Zi Liu; Tao Wang
Journal:  RSC Adv       Date:  2019-07-18       Impact factor: 4.036

3.  Diagnostic, Prognostic, and Predictive Molecular Biomarkers and the Utility of Molecular Imaging in Common Gastrointestinal Tumors.

Authors:  Michael O Idowu; Jennifer Laudadio; Kathryn Rizzo
Journal:  Biomed Res Int       Date:  2015-11-04       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.